The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Automation & Control
Blog: Poor Emils Almanac
Never known for his shyness, NIR expert Emil Ciurczak shares his unedited and uncensored perspectives on the industry he knows so well. Write in and let him know what you think.
Nov. 5, 2007
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Charles River reports lower Q4 2025 revenue in struggling CDMO business
UK pharmaceuticals exempt from tariffs in US drug pricing agreement
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Trending
Charles River inks agreement to divest CDMO, cell solutions businesses to GI Partners
WuXi Biologics accelerates development, manufacturing with robust model, platforms
A mix of old and new, Basel emerges as a leading European biopharma hub
Sponsored Picks
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Sponsored
2026 Manufacturing Medical Device Trends for Life Sciences
Load More Content